MGO One Seven LLC Acquires 1,089 Shares of CME Group Inc. $CME

MGO One Seven LLC raised its holdings in CME Group Inc. (NASDAQ:CMEFree Report) by 19.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,553 shares of the financial services provider’s stock after buying an additional 1,089 shares during the quarter. MGO One Seven LLC’s holdings in CME Group were worth $1,806,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Vanguard Group Inc. increased its holdings in CME Group by 1.2% in the 1st quarter. Vanguard Group Inc. now owns 34,643,827 shares of the financial services provider’s stock valued at $9,190,661,000 after buying an additional 400,737 shares during the period. Raymond James Financial Inc. grew its holdings in shares of CME Group by 9.7% in the 1st quarter. Raymond James Financial Inc. now owns 4,113,991 shares of the financial services provider’s stock worth $1,091,401,000 after purchasing an additional 363,130 shares during the last quarter. Vontobel Holding Ltd. grew its holdings in shares of CME Group by 3.0% in the 2nd quarter. Vontobel Holding Ltd. now owns 2,920,046 shares of the financial services provider’s stock worth $804,823,000 after purchasing an additional 84,005 shares during the last quarter. Massachusetts Financial Services Co. MA grew its holdings in shares of CME Group by 29.9% in the 1st quarter. Massachusetts Financial Services Co. MA now owns 2,818,590 shares of the financial services provider’s stock worth $747,744,000 after purchasing an additional 648,591 shares during the last quarter. Finally, AQR Capital Management LLC grew its holdings in shares of CME Group by 10.3% in the 1st quarter. AQR Capital Management LLC now owns 2,783,759 shares of the financial services provider’s stock worth $735,539,000 after purchasing an additional 260,065 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Up 0.4%

Shares of NASDAQ CME opened at $268.15 on Thursday. The firm’s 50-day simple moving average is $267.96 and its 200 day simple moving average is $271.30. The company has a market cap of $96.64 billion, a price-to-earnings ratio of 25.96, a price-to-earnings-growth ratio of 6.13 and a beta of 0.41. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 12-month low of $213.94 and a 12-month high of $290.79.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.05. The business had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The firm’s quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.56 EPS. On average, research analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were given a dividend of $1.25 per share. The ex-dividend date was Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. CME Group’s dividend payout ratio is presently 48.40%.

Insider Buying and Selling at CME Group

In other CME Group news, General Counsel Jonathan L. Marcus sold 392 shares of the company’s stock in a transaction dated Thursday, September 18th. The shares were sold at an average price of $262.00, for a total transaction of $102,704.00. Following the transaction, the general counsel directly owned 7,851 shares in the company, valued at approximately $2,056,962. This represents a 4.76% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Sunil Cutinho sold 11,896 shares of the company’s stock in a transaction dated Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the transaction, the insider owned 17,440 shares in the company, valued at approximately $4,734,436.80. The trade was a 40.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 13,043 shares of company stock valued at $3,527,956. 0.30% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

CME has been the topic of several analyst reports. Keefe, Bruyette & Woods upped their target price on shares of CME Group from $283.00 to $287.00 and gave the stock a “market perform” rating in a report on Monday. Piper Sandler upped their target price on shares of CME Group from $283.00 to $296.00 and gave the stock an “overweight” rating in a report on Tuesday, July 15th. Morgan Stanley upped their target price on shares of CME Group from $303.00 to $312.00 and gave the stock an “overweight” rating in a report on Wednesday, October 1st. Raymond James Financial lowered their target price on shares of CME Group from $309.00 to $307.00 and set an “outperform” rating on the stock in a report on Monday. Finally, JPMorgan Chase & Co. upped their target price on shares of CME Group from $252.00 to $256.00 and gave the stock an “underweight” rating in a report on Tuesday. Seven research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $283.71.

Get Our Latest Report on CME Group

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.